Growth Metrics

Solesence (SLSN) Liabilities and Shareholders Equity (2016 - 2025)

Solesence (SLSN) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $54.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity rose 12.36% year-over-year to $54.0 million, compared with a TTM value of $221.0 million through Sep 2025, up 37.86%, and an annual FY2024 reading of $50.0 million, up 52.07% over the prior year.
  • Liabilities and Shareholders Equity was $54.0 million for Q3 2025 at Solesence, down from $60.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $60.0 million in Q2 2025 and bottomed at $16.0 million in Q2 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $36.5 million, with a median of $34.0 million recorded in 2022.
  • The sharpest move saw Liabilities and Shareholders Equity surged 115.07% in 2022, then fell 5.0% in 2023.
  • Year by year, Liabilities and Shareholders Equity stood at $28.4 million in 2021, then rose by 18.19% to $33.6 million in 2022, then decreased by 2.02% to $32.9 million in 2023, then skyrocketed by 52.07% to $50.0 million in 2024, then rose by 7.97% to $54.0 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for SLSN at $54.0 million in Q3 2025, $60.0 million in Q2 2025, and $57.0 million in Q1 2025.